The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation

The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation

Systematic glucocorticosteroids (GCS) are used to treat chronic obstructive pulmonary disease (COPD) and can cause leukocytosis. Distinguishing the effect of GCS on leukocyte level from infection-induced leukocytosis is important. We sought to quantify the effect of chronic GCS treatment on leukocyt...

Full description

Bibliographic Details
Main Authors: Amit Frenkel, Eric Kachko, Victor Novack, Moti Klein, Evgeni Brotfain, Leonid Koyfman, Nimrod Maimon
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Clinical Medicine
Subjects:
glucocorticosteroids (gcs)
chronic obstructive pulmonary disease (copd)
leukocytosis
eosinophils
Online Access:https://www.mdpi.com/2077-0383/8/10/1697

Internet

https://www.mdpi.com/2077-0383/8/10/1697

Similar Items